A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis
about
Mometasone furoate nasal spray: a systematic reviewSublingual immunotherapy for pediatric allergic rhinitis: The clinical evidenceChoosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dose"The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis".Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical AssoEfficacy of allergen immunotherapy in reducing the likelihood of developing new allergen sensitizations: a systematic review.Allergen immunotherapy for the treatment of allergic rhinitis and/or asthma: an umbrella reviewEvaluation of a sublingual immunotherapy solution in olive-induced respiratory allergy in Jordan: a retrospective observational study.Five-grass-pollen sublingual immunotherapy tablet for the treatment of grass-pollen-induced allergic rhinoconjunctivitis: 5 years of experience.Sublingual allergen immunotherapy for respiratory allergies: what is new?Advances in allergen immunotherapy: aiming for complete tolerance to allergens.Current developments for improving efficacy of allergy vaccines.The Future of Sublingual Immunotherapy in the United States.Sublingual immunotherapy for allergic rhinitis: where are we now?Safety evaluation of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) for allergic rhinitis.Relevance of a 5-grass sublingual tablet for immunotherapy of patients with grass pollen allergy in North America.Investigational new drugs for allergic rhinitis.Allergic Rhinitis Control Test questionnaire-driven stepwise strategy to improve allergic rhinitis control: a prospective study.Sublingual immunotherapy tablets as a disease-modifying add-on treatment option to pharmacotherapy for allergic rhinitis and asthma.Specific delivery of an immunosuppressive drug to splenic B cells by antigen-modified liposomes and its antiallergic effect.
P2860
Q26747719-68D920A3-D30E-4513-8FC9-FDEC32049C85Q26767010-5EADF986-83F7-4344-B25D-83B7362B4A3EQ26772069-E9F886B7-C4E5-4844-999E-1C678E14D1C1Q35564301-3A850F96-CE8F-4BC5-9F50-C2D2C978B20DQ35777126-56422B00-7102-4AEA-8973-DFB707BCEF6EQ36215069-138F529D-BF14-4750-9109-562B6699A366Q36369716-08EFB4B6-746F-49BC-9739-41CCCD82635DQ37682822-7948C3E0-58CA-4BD4-8D75-37C0703D8E89Q38247821-5D5CA5E9-F4CE-47B2-BB62-816FC5695B5EQ38269285-A8E62101-DC92-4901-AAC7-5C4F0CCCC291Q38391526-9ACCDB04-DA56-4C2F-8504-3C074525C6C4Q38503330-1DCCAD18-ACCD-45EB-AF1E-B483FF61F7CBQ38543371-5BB3BA07-BDE4-40E3-B1C1-E5E83225E793Q38617692-9D90A46E-4049-44FA-ADA6-5273221A9D37Q38637608-119876B5-8454-47C5-A57A-41F3DBA55C3CQ38712422-F63BE148-21E3-4BE5-92F3-CF66905342C9Q39111947-4EC17C7B-4D56-47A3-A029-C7F17DDBD4CFQ40687766-6BE56B48-BE3E-4EDE-8621-8EB904A91A03Q47943200-74D6F4C7-0799-4F03-AC82-F96440797BF8Q50865496-769FC87B-FDAD-44CC-91FB-948AE0535948
P2860
A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A meta-analysis of sublingual ...... l allergic rhinoconjunctivitis
@ast
A meta-analysis of sublingual ...... l allergic rhinoconjunctivitis
@en
type
label
A meta-analysis of sublingual ...... l allergic rhinoconjunctivitis
@ast
A meta-analysis of sublingual ...... l allergic rhinoconjunctivitis
@en
prefLabel
A meta-analysis of sublingual ...... l allergic rhinoconjunctivitis
@ast
A meta-analysis of sublingual ...... l allergic rhinoconjunctivitis
@en
P2093
P2860
P921
P356
P1433
P1476
A meta-analysis of sublingual ...... l allergic rhinoconjunctivitis
@en
P2093
Jean-François Dreyfus
Moisés A Calderón
Philippe Devillier
P2860
P2888
P356
10.1186/1741-7015-12-71
P407
P50
P5008
P577
2014-05-01T00:00:00Z
P5875
P6179
1006665059